Any person will be able to receive crypto currency in exchange for access of the pharmaceutical companies to data about their genome. The startup of Nebula Genomics, founded by the leading geneticist from Harvard, George Church, suggests the decoding of the genome for $ 1,000. , protection of the sequencing results through the block system and the ability to earn virtual currency for granting access to third parties to the decoded genetic data, writes MIT Technology Review. The startup of Nebula Genomics is the brainchild of Harvard graduates and Professor George Church. The company wants to monetize personal genetic information, allowing people to sell access to it for crypto currency. Today, when you pay for testing DNA through 23andMe, Helix or Ancestry. com, the company that conducts testing owns your genetic data and can dispose of them as you like. Nebula Genomics wants to restore the right to own the decoding of the genome to its "bearers". Church and his colleagues say that pharmaceutical and biotech companies need data on the genome for developing new drugs. Usually they buy this data from academic institutions or companies analyzing genetic data, such as 23andMe, often for millions of dollars.

Nebula Genomics wants to eliminate intermediaries so that people can sell their genetic data to pharmaceutical companies directly. Buyers will not actually be able to download data and receive them for unlimited use. Instead, they will only have temporary access. Data owners will remain anonymous, while buyers must be completely transparent. Genomic data and transaction records will be protected by a blocking system - the same technology used for crypto currency, for example, bitkoyna.

Original article: Startup offers to sell access to the genome for crypto currency.